DAB2IP and breast carcinoma: Here we show that DAB2IP protein expression is lost in some grade 2/stage II or higher ER+ breast tumors, thereby suggesting that DAB2IP loss in ER+ breast cancer contributes to a more aggressive stage of disease (Figure 3).